Buy Glenmark Pharma, price target Rs 375: Kunal Bothra

Kunal Bothra of Independent Analyst has a buy call on Glenmark Pharmaceuticals Ltd. with a target price of Rs 375.0 . The current price of Glenmark Pharmaceuticals Ltd. is Rs 356.25 . Kunal Bothra recommended to keep a stoploss at Rs 340 .

Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 9671.31 Crore) operating in Pharmaceuticals sector.

Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6042.06 Crore to Sales Value (93.93 % of Total Sales), Other Operating Revenue which contributed Rs 335.83 Crore to Sales Value (5.22 % of Total Sales) and Sale of services which contributed Rs 54.00 Crore to Sales Value (0.83 % of Total Sales)for the year ending 31-Mar-2018.


For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 2763.73 Crore, up 21.02 % from last quarter Sales of Rs 2283.60 Crore and up 8.81 % from last year same quarter Sales of Rs 2539.86 Crore Company has reported net profit after tax of Rs 255.54 Crore in latest quarter.

The company’s top management includes Dr.Brian W Tempest, Mr.Bernard Munos, Mr.D R Mehta, Mr.Glenn Saldanha, Mr.Julio Ribeiro, Mr.Milind Sarwate, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mr.V S Mani, Mrs.B E Saldanha, Mrs.Cherylann Pinto, Ms.Saira Ramasastry. Company has Walker, Chandiok & Co.LLP as its auditoRs As on 30-06-2019, the company has a total of 282,168,156 shares outstanding.